DZHK is a global meeting of world leading scientists to discuss the question: How can the benefits of medical research reach the patient?
Biotech Showcase is an investor conference at which companies are able to showcase their organisation to life science investors and strategic partners.
The disruptive nature of cell and gene therapies means that the need for advice and assistance in the regulatory area is particularly high. In this webinar the team at Cell and Gene Therapy Catapult will address how best to go about gaining early regulatory advice and how to engage with regulators globally, drawing on their own experiences.
Genesis 2018 will assemble senior executives and decision makers from across the Life Science and Healthcare field to present, discuss and demonstrate their collective insight and thought leadership for the sector, themselves and their stakeholders.
Bioregate Forum is a biennial European meeting dedicated to highlighting latest scientific, technological, clinical & commercialization approaches in the field of cell & gene therapy, stem cells, biomaterials and tissue engineering.
This conference brings together academic and industry participants focusing on many aspects of this rapidly expanding and evolving field including stem cells for cellular therapy, iPSCs and their deployment for research, pharmaceutical discovery and cellular therapy, immuno-oncology (IO) including CAR-T cell research and clinical application.
Learn about the progression and commercialisation of cell and gene therapies.
The ASH Annual Meeting covers malignant and non-malignant hematology.
The 1-day conference aims to provide an overview about the successes, challenges and areas for future development.